The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Editorial
PreviousPrevious
Volume 342:1664-1666 June 1, 2000 Number 22
NextNext

New Therapeutic Approaches to Crohn's Disease

Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

 Sign up for free e-toc
 

This Article
-Full Text
-Purchase this article

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited

More Information
-Related Article
 by Feagan, B. G.
-Related Article
 by Slonim, A. E.
-PubMed Citation
Crohn's disease is an idiopathic, immunologically mediated disorder in which medically or surgically induced remissions are followed by relapses. The goals of treatment are to induce and then maintain remission through the long-term use of nontoxic agents.1 Several medications that are effective in the short term do not result in sustained remission, and conversely, agents used for maintenance may have minimal effects on active disease. For example, prednisone usually suppresses active inflammation, but long-term use is associated with high rates of relapse and unacceptable toxicity. The most effective drugs for maintenance therapy — mercaptopurine and azathioprine — have limited immediate . . . [Full Text of this Article]

References


This article has been cited by other articles:



HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2008 Massachusetts Medical Society. All rights reserved.